Author
Listed:
- Magdalena Paolino
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Axel Choidas
(Lead Discovery Center GmbH, D-44227 Dortmund, Germany)
- Stephanie Wallner
(Medical University Innsbruck, 6020 Innsbruck, Austria)
- Blanka Pranjic
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Iris Uribesalgo
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Stefanie Loeser
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Amanda M. Jamieson
(Brown University)
- Wallace Y. Langdon
(School of Pathology and Laboratory Medicine, University of Western Australia, Crawley, Western Australia 6009, Perth, Australia)
- Fumiyo Ikeda
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Juan Pablo Fededa
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Shane J. Cronin
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Roberto Nitsch
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
- Carsten Schultz-Fademrecht
(Lead Discovery Center GmbH, D-44227 Dortmund, Germany)
- Jan Eickhoff
(Lead Discovery Center GmbH, D-44227 Dortmund, Germany)
- Sascha Menninger
(Lead Discovery Center GmbH, D-44227 Dortmund, Germany)
- Anke Unger
(Lead Discovery Center GmbH, D-44227 Dortmund, Germany)
- Robert Torka
(Max-Planck, Institute for Biochemistry, D-82152 Martinsried, Germany)
- Thomas Gruber
(Medical University Innsbruck, 6020 Innsbruck, Austria)
- Reinhard Hinterleitner
(Medical University Innsbruck, 6020 Innsbruck, Austria)
- Gottfried Baier
(Medical University Innsbruck, 6020 Innsbruck, Austria)
- Dominik Wolf
(Medical University Innsbruck, 6020 Innsbruck, Austria
Internal Medicine III, University Hospital Bonn, 53127 Bonn, Germany)
- Axel Ullrich
(Max-Planck, Institute for Biochemistry, D-82152 Martinsried, Germany)
- Bert M. Klebl
(Lead Discovery Center GmbH, D-44227 Dortmund, Germany)
- Josef M. Penninger
(IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria)
Abstract
The E3 ligase Cbl-b acts on TAM tyrosine kinase receptors and has a critical role in the regulation of natural killer (NK) cell rejection of metastatic tumours; a small molecule TAM kinase inhibitor is shown to enhance the anti-metastatic NK cell activity.
Suggested Citation
Magdalena Paolino & Axel Choidas & Stephanie Wallner & Blanka Pranjic & Iris Uribesalgo & Stefanie Loeser & Amanda M. Jamieson & Wallace Y. Langdon & Fumiyo Ikeda & Juan Pablo Fededa & Shane J. Cronin, 2014.
"The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells,"
Nature, Nature, vol. 507(7493), pages 508-512, March.
Handle:
RePEc:nat:nature:v:507:y:2014:i:7493:d:10.1038_nature12998
DOI: 10.1038/nature12998
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:507:y:2014:i:7493:d:10.1038_nature12998. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.